GPR52 Comp-43 is a GPR52 receptor antagonist (IC50 = 0.63 μM). The use of GPR52 Comp-43 in animal models of Huntington's Disease leads to degradation and reduction of soluble and aggregated mutant huntingtin protein in the striatum. It also reduces neuronal loss, promotes neuronal survival and improves motor functions
in vivo
. GPR52 Comp-43 is active
in vitro
Caractéristiques techniques
| Marque | Tocris Bioscience |
|---|
| Réf. B-LABO | BL-RE-124447 |
|---|
| Réf. fabricant | 18776716 |
|---|
| Nom chimique ou matériau | (2 E)-5-Phenyl-1-(2-thienyl)-2-penten-1-one |
|---|
| CAS | 1239987-91-7 |
|---|
| Quantité | 50 mg |
|---|
| Cible | Orphan 7-TM Receptor Antagonists |
|---|
| Formule moléculaire | C<sub>15</sub>H<sub>14</sub>OS |
|---|
| Pureté | 0.98 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
